Acceder Registro /

ESMERALDA GARCÍA TORRALBA

Buscador

Garcia-Torralba E, Perez Ramos M, Ivars Rubio A, Navarro Manzano E, Blaya Boluda N, Lloret Gil M, Aller A, de la Morena Barrio P, Garcia Garre E, Martinez Diaz F, Garcia Molina F, Chaves Benito A, Garcia-Martinez E, Ayala de la Pena F. Deconstructing neutrophil to lymphocyte ratio (NLR) in early breast cancer: lack of prognostic utility and biological correlates across tumor subtypes. Breast Cancer Res Treat. 2024 Mar 7. doi: 10.1007/s10549-024-07286-x. Online ahead of print. PubMed PMID: 38453782.
AÑO: 2024; IF: 3.8
Cruz-Castellanos P, Gil-Raga M, Jimenez-Fonseca P, Ghanem I, Hernandez R, Piera-Molons N, Cano JM, Gallego-Martinez A, Garcia-Torralba E, Calderon C. Uncertainty and hope in relation to anxiety and depression in advanced lung cancer. BMJ Support Palliat Care. 2024 Jan 8;13(e3):e847-e850. doi: 10.1136/spcare-2022-003882. PubMed PMID: 36100428.
AÑO: 2024; IF: 2.7
Garcia-Torralba E, Navarro Manzano E, Luengo-Gil G, De la Morena Barrio P, Chaves Benito A, Perez-Ramos M, Alvarez-Abril B, Ivars Rubio A, Garcia-Garre E, Ayala de la Pena F, Garcia-Martinez E. A new prognostic model including immune biomarkers, genomic proliferation tumor markers (AURKA and MYBL2) and clinical-pathological features optimizes prognosis in neoadjuvant breast cancer patients. Front Oncol. 2023 May 29;13:1182725. doi: 10.3389/fonc.2023.1182725. eCollection 2023. PubMed PMID: 37313470; PubMed Central PMCID: PMC10258327.
AÑO: 2023; IF: 4.7
Garcia-Torralba E, Perez Ramos M, Ivars Rubio A, Navarro-Manzano E, Blaya Boluda N, de la Morena Barrio P, Garcia-Garre E, Martinez Diaz F, Chaves-Benito A, Garcia-Martinez E, Ayala de la Pena F. Clinical Meaning of Stromal Tumor Infiltrating Lymphocytes (sTIL) in Early Luminal B Breast Cancer. Cancers (Basel). 2023 May 20;15(10):2846. doi: 10.3390/cancers15102846. PubMed PMID: 37345183; PubMed Central PMCID: PMC10216816.
AÑO: 2023; IF: 5.2
Navarro Santana B, Garcia Torralba E, Verdu Soriano J, Laseca M, Martin Martinez A. Protective ostomies in ovarian cancer surgery: a systematic review and meta-analysis. J Gynecol Oncol. 2022 Mar;33(2):e21. doi: 10.3802/jgo.2022.33.e21. PubMed PMID: 35245000; PubMed Central PMCID: PMC8899871.
AÑO: 2022; IF: 3.9

Instituto de Investigación Sanitaria Acreditado

ISCII

Fondo Social Europeo "El FSE Invierte en tu futuro"

Fondo Social Europeo

Sello de Calidad Europeo "HR Excellence in Research"

HRS4R